Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis.
about
MPNs as Inflammatory Diseases: The Evidence, Consequences, and PerspectivesCytokine Regulation of Microenvironmental Cells in Myeloproliferative NeoplasmsThe Role of Reactive Oxygen Species in Myelofibrosis and Related NeoplasmsMicroarray and Proteomic Analyses of Myeloproliferative Neoplasms with a Highlight on the mTOR Signaling PathwayA 7-Gene Signature Depicts the Biochemical Profile of Early Prefibrotic MyelofibrosisA new internet-based tool for reporting and analysing patient-reported outcomes and the feasibility of repeated data collection from patients with myeloproliferative neoplasms.Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis.A novel, somatic, transforming mutation in the extracellular domain of Epidermal Growth Factor Receptor identified in myeloproliferative neoplasm.Whole blood transcriptional profiling reveals deregulation of oxidative and antioxidative defence genes in myelofibrosis and related neoplasms. Potential implications of downregulation of Nrf2 for genomic instability and disease progression.The impact of ruxolitinib treatment on inflammation-mediated comorbidities in myelofibrosis and related neoplasmsTranscriptomic alterations in the heart of non-obese type 2 diabetic Goto-Kakizaki ratsMolecular determinants of pathogenesis and clinical phenotype in myeloproliferative neoplasms.Driver mutations (JAK2V617F, MPLW515L/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera.Smoking and philadelphia-negative chronic myeloproliferative neoplasms.Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer developmentTranscriptional profiling of whole blood identifies a unique 5-gene signature for myelofibrosis and imminent myelofibrosis transformation.Circulating YKL-40 in myelofibrosis a potential novel biomarker of disease activity and the inflammatory state.Perspectives on the increased risk of second cancer in patients with essential thrombocythemia, polycythemia vera and myelofibrosis.Expression of CD markers in JAK2 positive myeloproliferative neoplasms: Prognostic significance
P2860
Q26775996-F27D814C-24F1-40E2-B97F-46603DBD4202Q26778929-AC40C5EA-BACC-4338-8863-B393B910C41CQ26779929-18584A96-04AE-4A72-911A-3E52B1C86B89Q28547283-0A6FFA06-8BD1-4BC0-A67C-B1F4A6A7FA6CQ28553797-5613F9DF-D224-4B4A-B583-7CAADD8E2D48Q30992878-479F8FA4-EA4A-4165-BDC3-C8EC34F75DC0Q33697252-01097C94-CF97-4572-914F-3A0776EE99FCQ33732661-FE08388A-71A9-4BBE-86DE-4C569CF7C2F3Q34514329-DC49EAF4-03C2-462D-84A8-0C752FB80A87Q35841839-446282DD-714C-4C90-8DED-E04AEB9CB87AQ37156557-C5E274D1-8584-4C91-A86F-B9089D1E3367Q37555785-2236FD54-4015-4B23-AB6B-7F63F89A54F4Q37661411-43156950-ECE8-4873-9241-51CFADA9A029Q41348010-1F4A374D-BE3A-4675-99B2-1FE1F3982F82Q41576528-B47FB3A9-1B24-4D62-9111-0AB698613B46Q41809175-132E06E0-3E57-4025-9EC5-F447F041963EQ42221121-4DE4E95F-4205-4168-9306-7E397F425854Q53680800-CC0B5B76-6B04-47AE-9412-A6AEFCEEB28AQ58587352-4DB59041-E64F-482A-9FA5-35BC84B57D9E
P2860
Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Gene expression profiling with ...... ythemia vera to myelofibrosis.
@en
type
label
Gene expression profiling with ...... ythemia vera to myelofibrosis.
@en
prefLabel
Gene expression profiling with ...... ythemia vera to myelofibrosis.
@en
P2093
P1476
Gene expression profiling with ...... ythemia vera to myelofibrosis.
@en
P2093
Caroline H Riley
Hans Carl Hasselbalch
Mads Thomassen
Morten K Jensen
Thomas Stauffer Larsen
Torben A Kruse
P304
771-780.e19
P356
10.1016/J.EXPHEM.2012.05.011
P577
2012-06-01T00:00:00Z